give me a session by session plan for pt withb tracheostomy and dyspagia aspiration on thin liquids
Reading File
Finding Sources
Finding Sources
Searching PubMed
tracheostomy dysphagia aspiration rehabilitation swallowing therapy
Finding Sources
Finding Sources
Searching PubMed
tracheostomy dysphagia swallowing rehabilitation
Finding Sources
Searching PubMed
"tracheostomy" AND "aspiration" AND "speaking valve" AND "swallowing"
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Searching the Web
speech therapy session plan tracheostomy dysphagia aspiration thin liquids Passy Muir valve protocol
I now have enough clinical context from the patient's discharge summary and literature to construct a comprehensive, evidence-based session-by-session plan. Let me compile the full plan.
Patient Summary (from Discharge)
Rohit Santosh Holkar | Male, 23 y/o
- RTA → Right mandibular fracture → ORIF + Tracheostomy (12/02/2026)
- Currently on RT (Ryle's tube) feeds
- Has had 8 days of speech swallow therapy previously
- Aspiration on thin liquids (confirmed on assessment)
- No c/o odynophagia, regurgitation
- CNS: conscious and oriented
Session-by-Session Swallowing Therapy Plan
Phase 1: Assessment & Baseline (Sessions 1–2)
Session 1 — Clinical Swallowing Evaluation (CSE)
| Domain | What to Do |
|---|---|
| Oral motor exam | Lip seal, tongue ROM/strength, jaw opening (cautious — ORIF in situ), buccal tone |
| Tracheostomy status | Confirm tube type (cuffed/uncuffed), cuff status, tube size; check secretion management |
| Secretion control | Suction and observe: quantity, color, consistency |
| Cough | Assess volitional cough strength with cuff deflated |
| Voice | Check wet/gurgling voice quality with cuff deflated |
| Blue Dye Test (Evans Blue Dye) | With cuff deflated + finger occlusion of trach — trial with a colored bolus (ice chips/thick liquid); check for blue secretions on suction within 30–60 min |
| Positioning assessment | Head/neck position tolerance given mandibular ORIF |
Goals: Establish baseline, confirm aspiration on thin liquids (already noted), identify oral-pharyngeal phase deficits.
Session 2 — Cuff Deflation Trial + PMV (Passy Muir Valve) Introduction
| Step | Details |
|---|---|
| Cuff deflation protocol | Suction above and below cuff → slowly deflate → monitor SpO₂, RR, comfort |
| Duration | Begin with 5–10 min cuff-deflated, increase by 5 min each session |
| PMV trial | If patient tolerates cuff deflation: attempt PMV placement (1-way speaking valve — restores subglottic pressure, improves laryngeal sensation, reduces aspiration) |
| Evidence | PMV restores pharyngeal sensation and reduces aspiration in tracheostomized patients (O'Connor et al., 2019) |
| Education | Counsel patient + family on dysphagia, NPO status rationale, tube feed importance |
Phase 2: Indirect + Early Direct Therapy (Sessions 3–6)
Sessions 3–4 — Oral Motor & Sensorimotor Exercises (No food yet)
| Exercise | Technique | Reps/Sets |
|---|---|---|
| Lip strengthening | IOPI or button/tongue depressor resistance | 10 × 3 |
| Tongue base retraction | "Gargling" motion, tongue hold exercise | 10 × 3 |
| Shaker / Head Lift Exercise | Supine head raises (strengthens suprahyoid/UES opening muscles) | 3 × 30 sustained + 30 repetitive |
| Jaw ROM | Gentle active-assisted opening — careful around ORIF site | As tolerated |
| Mendelsohn maneuver practice | Dry swallow with laryngeal elevation hold | 5–10 × |
| Effortful swallow | Dry swallow with maximal effort | 10 × |
| Thermal-tactile stimulation | Cold laryngeal mirror or ice on anterior faucial pillars to heighten swallow reflex | Pre-swallow |
Continue: PMV trials → increase to 30–60 min tolerance; continue cuff deflation extended periods.
Sessions 5–6 — Direct Therapy: Compensatory Strategies + Modified Textures
Since aspiration is on thin liquids, begin direct trials avoiding thin liquids.
| Bolus Consistency | Rationale |
|---|---|
| Ice chips (small) | Minimal volume, slow melt, therapeutic |
| Nectar-thick liquids (IDDSI Level 2) | Slower bolus transit, reduced aspiration risk |
| Pureed solids (IDDSI Level 4) | Cohesive, manageable, less residue |
Compensatory strategies to trial:
| Strategy | Mechanism |
|---|---|
| Chin tuck (chin-down posture) | Widens valleculae, reduces premature spillage, deflects bolus posteriorly |
| Head turn to stronger side | If pharyngeal weakness is asymmetric |
| Small sip size (1–2 ml) | Reduces bolus volume and aspiration risk |
| Slow rate of intake | Allows complete laryngeal closure per bolus |
| Double swallow / multiple swallows | Clears pyriform sinus residue |
| Cough after swallow | Expels residue from laryngeal inlet |
Monitoring each session: SpO₂ pre/during/post, wet voice quality, voluntary cough after each bolus, suction check for stained secretions.
Phase 3: Progressive Oral Intake (Sessions 7–10)
Session 7 — Expand Volume Trials + Mealtime Practice
- Upgrade to 10 ml boluses of nectar-thick if sessions 5–6 were safe
- Introduce a small structured meal trial: pureed/soft foods (IDDSI 4–5)
- Continue Shaker, Mendelsohn, effortful swallows as part of daily home program
- Assess fatigue across a 10–15 min meal simulation
Session 8 — Instrumental Assessment Consideration
If resources available (and aspiration persistence suspected):
- FEES (Fiberoptic Endoscopic Evaluation of Swallowing) — this patient already had FEES+FOL on 26/03/2026 per discharge summary → review those findings
- Re-FEES if status has changed, or if advancing to thin liquids is being considered
- VFSS (Videofluoroscopy) — if FEES unavailable; evaluates all 3 phases, timing of aspiration (before/during/after swallow), laryngeal elevation, UES opening
Sessions 9–10 — Thin Liquid Trials with Strategies
Only when:
- Aspiration on thick liquids has resolved
- Laryngeal sensation has improved (often coincides with improved PMV tolerance)
- Strong voluntary cough is present
| Trial | Approach |
|---|---|
| Very thin with chin tuck | 5 ml sip, assess with cervical auscultation |
| Carbonated thin liquid | Carbonation enhances sensory triggering of swallow reflex |
| Cold thin liquid | Cold bolus may trigger faster swallow reflex |
| Re-assess with FEES/VFSS | Confirm safety before liberalizing diet |
Phase 4: Decannulation Preparation (Sessions 11–14)
Decannulation readiness is intimately tied to swallowing safety. Criteria checklist each session:
| Criterion | Target |
|---|---|
| Manages secretions independently | Yes |
| Tolerates cuff deflation ≥ 4–8 hrs/day | Yes |
| PMV tolerance full day | Preferred |
| Adequate cough / airway protection | Strong volitional cough |
| Aspiration on thin liquids resolved or manageable | Verified instrumentally |
| No respiratory compromise | SpO₂ stable |
Session 11–12 — Cuff-Down Extended Trials + Tube Downsizing
- Coordinate with ENT/medical team for tube downsizing (from current to smaller fenestrated tube, then trial of plugging/capping)
- Continue swallowing exercises and oral intake trials with cuff down
Session 13–14 — Decannulation Trial + Post-Decannulation Swallow
- Tube capping trials (24–48 hrs)
- Formal swallowing reassessment after decannulation (pharyngeal mechanics often improve after decannulation due to restored subglottic pressure and laryngeal mobility)
- Advance diet to IDDSI Level 6 (soft & bite-sized) → Level 7 (regular) as tolerated
Phase 5: Post-Decannulation & Discharge Prep (Sessions 15–16)
Session 15 — Diet Liberalization + Home Program
- Formal post-decannulation FEES/VFSS if thin liquid aspiration persists
- Issue written home swallowing exercise program
- Caregiver training: safe feeding posture, bolus size, warning signs of aspiration (wet voice, coughing after meals, recurrent chest infections)
Session 16 — Discharge / Outpatient Handover
- Final swallowing function rating (Functional Oral Intake Scale, FOIS)
- Written diet and liquid texture recommendations (IDDSI level)
- Outpatient SLP referral if any residual aspiration
- ENT follow-up for tracheostomy wound care
Key Clinical Considerations for This Patient
| Factor | Relevance |
|---|---|
| Mandibular ORIF | Restricted jaw opening, altered oral preparatory phase; avoid large solid boluses; coordinate jaw ROM exercises with surgical team |
| Young age (23 y/o) | Good neuroplasticity and recovery potential; set expectation of full oral intake |
| Duration since tracheostomy (~3 months) | Risk of subglottic scarring, reduced laryngeal sensation from prolonged disuse |
| Previous 8 days SLT | Has some baseline — build on prior progress, re-assess what strategies were trialed |
| RT feeds ongoing | Do not remove RT until safe oral intake ≥ 75% of nutritional needs is confirmed |
| Conscious and oriented | Full participant in therapy; good cognitive engagement expected |
Outcome Measures to Track
- FOIS (Functional Oral Intake Scale) — baseline to discharge
- PAS (Penetration-Aspiration Scale) — from instrumental assessment
- DOSS (Dysphagia Outcome and Severity Scale)
- SpO₂ during meals
- Wet voice quality rating pre/post bolus
give me a session by session plan for this pt with tracheostomy and dyspagia aspiration on thin liquids
Finding Sources
Searching PubMed
tracheostomy dysphagia swallowing rehabilitation decannulation
Searching PubMed
"Passy Muir" OR "speaking valve" AND tracheostomy swallowing aspiration
Finding Sources
I now have all the clinical data needed. Here is the fully individualized plan based on the FEES report and discharge summary.
FEES Findings Summary (26/03/2026) — The Critical New Data
| Parameter | Finding |
|---|---|
| Indication | Decannulation assessment |
| Tracheostomy | YES — Portex 7.5mm ID |
| Ryles tube | YES |
| Gag reflex | Present |
| Dry swallow | Velopharyngeal closure, BOT, valleculae, epiglottis, pyriform fossa, laryngeal elevation — all NORMAL |
| Dry swallow | Pooling of secretions — PRESENT |
| Vocal folds | Mobile |
| Laryngeal adductor response | Bilateral — Present |
| Solid food trial | No pre-spillage, no penetration, no aspiration, no residue ✅ |
| Liquid trial | Penetration: YES / Aspiration: YES ⚠️ |
| PAS score | 7 (aspiration, no cough response noted — silent aspiration) |
| Advice | Continue RT feeds, continue speech & swallow therapy |
Key Clinical Interpretation
- Structural mechanics are largely intact (normal laryngeal elevation, adductor response, pyriform fossae)
- The aspiration is specifically on liquids, most likely due to reduced laryngeal sensitivity + secretion pooling from prolonged tracheostomy (since 12/02/2026, ~6.5 weeks by FEES date)
- Solid food is safe — this is a major therapeutic advantage
- PAS 7 = aspiration without spontaneous cough response → silent aspiration — highest priority to resolve before decannulation
- Goal: resolve liquid aspiration → decannulate → full oral diet
Session-by-Session Speech & Swallowing Therapy Plan
PHASE 1 — Consolidation & Foundation (Sessions 1–3)
Purpose: Re-establish baseline post-FEES, address secretion pooling, begin sensorimotor priming
Session 1 — Clinical Re-Baseline + Secretion Management
| Task | Detail |
|---|---|
| Review FEES with patient/family | Explain findings: safe with solids, aspirating liquids silently (PAS 7) |
| Oral hygiene protocol | Establish pre-meal oral care — reduces bacterial load in aspirated material; critical with silent aspiration |
| Secretion assessment | Observe secretion quantity, viscosity, color; train patient in voluntary throat clear + huff cough |
| Volitional cough training | "Huff" cough and forceful cough with cuff deflated — FEES shows no cough reflex on aspiration; building voluntary protective cough is a priority |
| Cuff deflation trial | 10–15 min with SpO₂ monitoring; suction pre/post |
| Oral motor screen | Lip seal, tongue ROM/strength, jaw opening (ORIF caution), buccal tone, soft palate movement |
| Patient education | Explain: NPO for liquids, thin liquids unsafe currently, solids can begin with SLP supervision |
Session 2 — PMV (Passy Muir Valve) Introduction + Sensory Priming
The FEES shows mobile vocal folds bilaterally and bilateral LAR present — PMV candidacy is favorable.
| Task | Detail |
|---|---|
| PMV trial | Cuff must be fully deflated before PMV placement; confirm no air leak, adequate SpO₂ |
| Duration target | Begin 15–20 min; increase by 10 min each session toward 4–8 hrs/day |
| Rationale | PMV restores subglottic pressure → improves laryngeal sensation → reduces penetration/aspiration (O'Connor et al., Heart Lung 2019, PMID 30573194) |
| Thermal-tactile stimulation (TTS) | Cold laryngeal mirror or chilled spoon to anterior faucial pillars × 5 strokes each side before swallowing trials → heightens swallow trigger speed |
| Dry swallow practice | 10 effortful dry swallows with laryngeal elevation hold (Mendelsohn) |
| Carbonated ice chips | Small carbonated ice chips (soda water frozen) — carbonation + cold = dual sensory input to enhance swallow trigger |
Session 3 — Commence Oral Intake: Solids (FEES confirmed safe)
FEES confirmed no aspiration on solids — begin structured oral solid trials immediately.
| Bolus | Volume | Posture | Monitoring |
|---|---|---|---|
| Pureed / IDDSI Level 4 | 5 ml teaspoon | Chin tuck, upright 90° | Wet voice, SpO₂, cough |
| Soft & Bite-sized / IDDSI Level 5 | Small bite | Chin tuck | Same |
| Progression target | Work toward structured 10–15 min meal | — | — |
Exercises this session (10 min pre-meal):
- Shaker head-lift: 3 × 1 min sustained + 30 consecutive (strengthens suprahyoids, improves UES opening)
- Effortful swallow × 10
- Tongue base retraction "pull-back" × 10
PHASE 2 — Sensory Rehabilitation + Liquid Aspiration Reduction (Sessions 4–8)
Purpose: Improve laryngeal sensitivity, build voluntary airway protection, systematically trial modified liquids
Session 4 — Solidify Solid Intake + Begin Modified Liquid Trials
| Modified Liquid | IDDSI Level | Rationale |
|---|---|---|
| Mildly thick / nectar-thick | Level 2 | Slower bolus transit; more time for laryngeal closure |
| Approach | 5 ml × 3 trials with chin tuck, assess with cervical auscultation + wet voice check | — |
| Do NOT trial | Thin water / standard liquids yet | PAS 7 on FEES |
Continue:
- PMV 30–45 min/session + patient to wear between sessions if tolerated
- TTS pre-swallow
- Voluntary cough training: 3 sets of 5 strong coughs, huff-cough series
Session 5 — Mendelsohn + Super-Supraglottic Swallow Technique
Specifically targeting the silent aspiration (no cough response on FEES):
| Technique | How to Teach | Goal |
|---|---|---|
| Super-supraglottic swallow | Breath-hold before bolus → bear down → swallow → cough immediately after | Voluntary laryngeal closure before + immediately after bolus — compensates for absent cough reflex |
| Mendelsohn maneuver | Feel larynx rise → hold at peak elevation for 2–3 sec during swallow | Prolongs UES opening, improves bolus clearance |
| Double swallow | Two sequential swallows per bolus | Clears any residue in laryngeal vestibule before next breath |
Practice these techniques with dry swallows first, then with IDDSI Level 2 liquid, 5 ml boluses.
Solid intake: Progress to IDDSI Level 6 (soft, no processing required) if Level 4–5 tolerated without residue or coughing.
Session 6 — Re-assess Penetration-Aspiration on Modified Liquids
Clinical assessment using:
- Wet/gurgling voice quality (most sensitive clinical marker)
- SpO₂ drop ≥ 3% from baseline
- Cervical auscultation — gurgles post-swallow
- Voluntary cough production after swallow
| Trial | Volume | Outcome expected |
|---|---|---|
| Nectar-thick (IDDSI 2) × 5 trials | 5 ml + 10 ml | Target: no wet voice, no SpO₂ drop |
| Moderately thick (IDDSI 3) if Level 2 fails | 5 ml | Slower transit, more laryngeal time |
If Level 2 safe: document and advance. If not: continue exercises for 2 more sessions before re-trial.
Sessions 7–8 — Generalise Oral Intake + Meal Training
| Goal | Activity |
|---|---|
| Supervised meal | Full 15–20 min meal — soft solids + nectar-thick fluids; monitor throughout |
| Fatigue assessment | Swallowing often deteriorates mid-meal; compare SpO₂ and voice quality at start vs end of meal |
| Independence | Patient self-monitors with learned strategies (chin tuck, double swallow, huff-cough post swallow) |
| PMV | Target: PMV worn for 4+ hrs/day consistently |
| Cough | Target: reliable voluntary cough produced within 2 sec of aspiration event |
PHASE 3 — Thin Liquid Trials (Sessions 9–11)
Only proceed if: (a) no aspiration on IDDSI Level 2 for 2 consecutive sessions, (b) reliable voluntary cough present, (c) PMV tolerated ≥ 2 hrs
Session 9 — Thin Liquid Introduction with Strategies
| Strategy | Mechanism |
|---|---|
| Chin tuck | Widens valleculae, provides additional bolus "catch" space |
| Sip size control (3–5 ml only) | Reduces volume of potential aspiration |
| Cold/carbonated water | Dual sensory stimulus (thermal + carbonation) → faster swallow trigger |
| Super-supraglottic swallow | Voluntary glottic closure pre-swallow |
Start with 3 ml cold water × 5 trials → assess with cervical auscultation + wet voice.
Sessions 10–11 — Thin Liquid Progression or Re-FEES
If thin liquid trials clinically safe (2 sessions):
- Arrange repeat FEES to objectively confirm — this is essential before decannulation
- A repeat FEES with thin liquids post-therapy showing PAS ≤ 3 (penetration without aspiration) or PAS 1–2 would support decannulation
If thin liquids still penetrating/aspirating clinically:
- Continue Level 2 (nectar-thick) as safe oral liquid
- Proceed to decannulation planning regardless if solids + thick liquids are safe (decannulation is not contingent on thin liquid clearance if patient is otherwise safe and can maintain nutrition)
PHASE 4 — Decannulation Preparation (Sessions 12–14)
Coordinate with ENT (Dr. Kalpana Rajivkumar) at each step
Decannulation checklist — assess every session:
| Criterion | Status to Confirm |
|---|---|
| Manages own secretions | No pooling, clears independently |
| PMV tolerance ≥ 4–8 hrs/day | ✅ Target |
| Cuff deflation tolerated all day | ✅ |
| Voluntary cough — strong | ✅ — Critical (FEES showed no reflex cough) |
| Oral intake safe: solids + thick liquids | ✅ Confirmed by FEES / clinical |
| Thin liquid safety confirmed OR decision made to decannulate with Level 2 restriction | Confirmed |
| No respiratory compromise | SpO₂ stable, AEBE on chest |
Session 12 — Capping Trials
- Downsizing: current Portex 7.5mm → smaller tube (6.0 or 5.0mm) via ENT team
- Fenestrated tube with cuff down → trial decannulation cap
- Start capping 1 hr → 4 hrs → overnight
Session 13 — Extended Capping + Swallow Under Capped Conditions
- Full swallowing trial with tube capped (simulates post-decannulation conditions)
- Solids + liquids with strategies
- Confirm no respiratory compromise over 24 hrs of capping
Session 14 — Decannulation (ENT-led, SLP present)
- SLP present at decannulation for immediate post-decannulation swallow assessment
- After decannulation: subglottic pressure and laryngeal mechanics typically improve significantly
- Expected improvement in thin liquid aspiration after decannulation
PHASE 5 — Post-Decannulation & Diet Liberalization (Sessions 15–16)
Session 15 — Post-Decannulation Swallow Reassessment
| Assessment | Method |
|---|---|
| Clinical swallow evaluation | All consistencies; assess voice quality (improved subglottic pressure?) |
| Repeat FEES if thin liquids still suspect | Gold standard confirmation |
| FOIS scoring | Aim for FOIS 5–6 (total oral diet with restrictions) toward FOIS 7 (no restrictions) |
Session 16 — Home Program + Discharge
| Component | Content |
|---|---|
| Written exercise program | Shaker × daily, effortful swallow × 3 sets, Mendelsohn × 10 |
| Diet prescription | IDDSI level clearly specified with written handout |
| Warning signs for family | Wet/gurgly voice after eating, frequent throat clearing, recurrent cough at meals, chest infections → return to SLP |
| Outpatient SLP referral | For thin liquid monitoring if still restricted |
| Oral hygiene reinforcement | Continue twice-daily oral care |
| Nutrition team liaison | Wean RT feeds as oral intake reaches 75–100% of daily requirements |
Session Summary Table
| Session | Phase | Key Focus |
|---|---|---|
| 1 | Assessment | Secretion management, cough training, oral screen |
| 2 | Foundation | PMV intro, TTS, sensory priming, carbonated ice chips |
| 3 | Oral intake | Solid food trials (FEES-confirmed safe), swallow exercises |
| 4 | Modified liquids | Nectar-thick (IDDSI 2) trials with chin tuck |
| 5 | Technique | Super-supraglottic swallow, Mendelsohn — target silent aspiration |
| 6 | Re-assess | Clinical marker check on IDDSI 2 liquids |
| 7–8 | Generalise | Full supervised meals, fatigue assessment, independence |
| 9 | Thin liquids | First cold/carbonated thin liquid trials with strategies |
| 10–11 | Re-FEES | Objective confirmation; advance or maintain restrictions |
| 12–13 | Decannulation prep | Capping trials, tube downsizing |
| 14 | Decannulation | ENT-led, SLP present |
| 15 | Post-decannulation | Reassessment, FOIS, diet liberalization |
| 16 | Discharge | Home program, written diet plan, outpatient referral |
Why This Patient Has Good Prognosis
- Young (23 y/o) — excellent neuroplasticity and recovery
- Normal laryngeal mechanics on FEES — elevation, adductor response, pyriform fossae all intact; problem is sensory, not structural
- Solids already safe — oral intake can begin now
- Gag reflex present, vocal folds mobile — positive prognostic signs
- Secretion pooling (the main issue) responds well to PMV and oral hygiene protocols
- No brain injury — unlike the decannulation literature's typical cohort; his mechanism is maxillofacial trauma, so central swallow control should be intact
References: Gallice et al., Dysphagia 2024 (PMID 38189928) — decannulation predictors; Eskildsen et al., Disabil Rehabil 2024 (PMID 37449332) — rehabilitative interventions for decannulation; O'Connor et al., Heart Lung 2019 (PMID 30573194) — PMV reduces aspiration; Ledl et al., HNO 2024 (PMID 38578463) — tracheostomy dysphagia therapy curriculum.
This is a shared conversation. Sign in to Orris to start your own chat.